ProMIS Neurosciences
Develops EpiSelect-discovered antibodies for protein-misfolding neurodegenerative disorders.
$13.79
After-hours close−0.10 (−0.68%)
At close$13.88(−0.79%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.31 | — | — |
| Aug 2026 | −$1.38 | −$1.28 | +7.2% |
| May 2026 | −$1.06 | −$1.26 | −18.9% |
| May 2026 | −$1.06 | −$1.26 | −18.9% |
| Mar 2026 | −$4.66 | −$4.11 | +11.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Dec 2020 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Dec 2018 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Dec 2017 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Dec 2016 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Dec 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$1.31 | — | — | — | — | — |
| Aug 13, 2026 | −$1.38 | −$1.28 | +7.2% | — | — | — |
| May 12, 2026 | −$1.06 | −$1.26 | −18.9% | — | — | — |
| May 11, 2026 | −$1.06 | −$1.26 | −18.9% | — | — | — |
| Mar 25, 2026 | −$4.66 | −$4.11 | +11.8% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 12, 2025 | ||||||
| Aug 13, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 14, 2024 | ||||||
| Apr 1, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 8, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 17, 2022 | ||||||
| Dec 31, 2021 | ||||||
| Nov 12, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 14, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Nov 11, 2020 | ||||||
| Aug 13, 2020 | ||||||
| May 13, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Nov 14, 2019 | ||||||
| Aug 13, 2019 | ||||||
| May 14, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Nov 13, 2018 | ||||||
| Aug 14, 2018 | ||||||
| May 11, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Nov 13, 2017 | ||||||
| Aug 11, 2017 | ||||||
| May 9, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Nov 2, 2016 | ||||||
| Aug 12, 2016 | ||||||
| May 11, 2016 | ||||||
| Dec 31, 2015 | ||||||